New class of radiopharmaceuticals offer fresh perspective on cancer imaging theranostics
New class of radiopharmaceuticals offer fresh perspective on cancer imaging, theranostics
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging describes a new class of radiopharmaceuticals, named radiohybrids, that offer a fresh perspective on cancer imaging and radioligand therapy.
More From BioPortfolio on "New class of radiopharmaceuticals offer fresh perspective on cancer imaging, theranostics"